⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AYTU News
AYTU BioPharma, Inc. Common Stock
Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City
accessnewswire.com
AYTU
Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City
accessnewswire.com
AYTU
Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
accessnewswire.com
AYTU
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
accessnewswire.com
AYTU
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
accessnewswire.com
AYTU
Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025
accessnewswire.com
AYTU
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
accessnewswire.com
AYTU
Aytu BioPharma to Present at Upcoming October 2025 Conferences
accessnewswire.com
AYTU
Aytu BioPharma to Present at Upcoming September 2025 Conferences
accessnewswire.com
AYTU
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
accessnewswire.com
AYTU